Efficacy of rituximab for glandular Sjö gren's disease according to international clinical trials
Sjögren's disease (SD) is a chronic autoimmune disease characterized by lymphoplasmacytic infiltration of the exocrine glands, leading to the development of their destruction and progressive functional failure. The prevalence of SD is about 5%, which makes it one of the most common autoimmune d...
Saved in:
| Main Author: | A. V. Torgashina |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2020-03-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/998 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Differential diagnosis of bacterial sialadenitis in a rheumatologist's practice: a case report
by: A. V. Torgashina
Published: (2019-03-01) -
Ultrasound examination of the salivary glands in Sjogren’s disease
by: A. V. Torgashina
Published: (2021-09-01) -
Development of lymphangioleiomyomatosis in a female patient with Sjö gren's disease: a review of literature and a case report
by: Yu. I. Khvan, et al.
Published: (2019-05-01) -
Meta-analysis of the efficacy and safety of rituximab in the treatment of primary Sjögren’s syndrome
by: Xiao Zheng, et al.
Published: (2025-06-01) -
Seropositive juvenile rheumatoid arthritis with Sjo gren's syndrome: features of diagnosis and treatment choice (a case report)
by: M. I. Kaleda, et al.
Published: (2019-09-01)